Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Tiberius Acquisition Corp (TIBR) Prices 15M Share IPO at $10/Sh
-
ProPhotonix Announces Grant of Options
-
Tiberius Acquisition Corporation Announces Pricing of $150,000,000 Initial Public Offering
-
Healthcare Realty Trust (HR) PT Lowered to $34 at Cantor Fitzgerald Citing Interest Rate Volatility
-
Cala Corporation Signs Agreement with Cosco Dalian Shipyard
-
Virtusa (VRTU) PT Raised to $60 at Cantor Fitzgerald
-
Prophotonix Announces Preliminary Results For The Year Ended December 31, 2017
-
Cantor Fitzgerald Starts R1 RCM Inc (RCM) at Overweight
-
Auryn Resources Announces US$8.5 Million Financing
-
Cantor Fitzgerald Remains Bullish on Aquinox Pharma (AQXP) Following 4Q
-
Coupa Software (COUP) PT Raised to $58 at Cantor Fitzgerald
-
Corbus Pharmaceuticals (CRBP) PT Raised to $32 at Cantor Fitzgerald
-
Advaxis (ADXS) PT Lowered to $5 at Cantor Fitzgerald; 'Hold on Durvalumab Trial'
-
Egalet Ltd (EGLT) PT Lowered to $3.50 at Cantor Fitzgerald
-
Amarin (AMRN): Outcomes Design Comparisons Are Overdone - Cantor Fitzgerald
-
Aclaris Therapeutis (ACRS): Eskata and Pipeline Should Drive Shares Higher - Cantor Fitzgerald
-
LSI Corporation (LSI) PT Lowered to $84 at Cantor Fitzgerald
-
Extra Space Storage (EXR) PT Raised to $86 at Cantor Fitzgerald
-
Global Medical REIT (GMRE) PT Lowered to $10 at Cantor Fitzgerald; 'Acquisitions Accelerating'
-
Sunesis Pharmaceuticals Inc. (SNSS) PT Raised to $4 at Cantor Fitzgerald
-
Form 4 NEWMARK GROUP, INC. For: Mar 06 Filed by: CANTOR FITZGERALD, L. P.
-
U.S. Physical Therapy (USPH) PT Raised to $90 at Cantor Fitzgerald
-
Orchid Island Capital Announces March 2018 Monthly Dividend and February 28, 2018 RMBS Portfolio Characteristics
-
Mudrick Capital Acquisition Corporation Class A Common Stock And Warrants To Commence Trading Separately On March 12, 2018
-
Dynavax Technologies (DVAX) PT Raised to $27 at Cantor Fitzgerald
-
Ocular Therapeutix (OCUL) PT Raised to $22 at Cantor Fitzgerald; 'Preparing for a Momentous 2018'
-
UPDATE: CytomX Therapeutics (CTMX) PT Raised to $40 at Cantor Fitzgerald
-
Flex Pharma (FLKS) PT Lowered to $6 at Cantor Fitzgerald
-
BGC Partners And Newmark Group To Repay Remaining Balance Of $575 Million Unsecured Senior Term Loan
-
Anthony Orso Joins NKF Capital Markets as President of Capital Markets Strategies
-
SELLAS Life Sciences Announces $10,700,000 Private Placement
-
OPKO Health (OPK): Thouoghts From Management Roadtrip - Cantor Fitzgerals
-
Rigel Pharmaceuticals (RIGL) PT Raised to $7 at Cantor Fitzgerald; 'Awaiting PDUFA in April'
-
Mesoblast Enters Into US$75 Million Non-Dilutive Credit Facility
-
Synergy Pharmaceuticals (SGYP) PT Lowered to $8 at Cantor Fitzgerald, Keeps 'Overweight'
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts CareTrust REIT (CTRE) at Overweight
-
Cantor Fitzgerald Starts Genocea Biosciences (GNCA) at Overweight
-
ProPhotonix Appoints Chief Financial Officer
-
After-Hours Stock Movers 03/05: (GNCA) (TNTR) (ALOG) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
-
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
-
Dermira (DERM) PT Lowered to $20 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Evolus (EOLS) at Overweight
-
eHealth (EHTH) PT Lowered to $20 at Cantor Fitzgerald
-
LTC Properties (LTC) PT Lowered to $45 at Cantor Fitzgerald
-
Aimmune Therapeutics (AIMT) PT Raised to $64 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Syneron Medical (ELOS) at Overweight
-
Aimmune Therapeutics Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Cantor Fitzgerald Downgrades Cross Country Healthcare (CCRN) to Neutral

